semaglutide trials disparities
Uncovering Semaglutide Costs Exposes 3 Racial Gaps
Only a small fraction of Black adults are enrolled in the pivotal semaglutide trials, with just 5% representation despite making up 13% of the U.S. obesity population. The gap reflects deeper systemic barriers that inflate overall drug costs and limit real-world effectiveness. Medical Disclaimer: This article is for informational